Shares of Mylan (NASDAQ:MYL) traded at a new 52-week high today of $28.46. So far today approximately 6.2 million shares have been exchanged, as compared to an average 30-day volume of 5.5 million shares.
Potential upside of 3.1% exists for Mylan, based on a current level of $28.36 and analysts' average consensus price target of $29.25. The stock should find initial support at its 50-day moving average (MA) of $25.76 and further support at its 200-day MA of $23.32.
Mylan share prices have moved between a 52-week high of $28.46 and a 52-week low of $15.49 and are now trading 83% above that low price at $28.36 per share. The 200-day and 50-day moving averages have moved 0.49% higher and 1.42% higher over the past week, respectively.
Mylan, Inc. develops, licenses, manufactures, markets, and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients . The Company sells its products to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, group purchasing organizations, and healthcare professionals.